ABSTRACT Sodium cromoglycate and nedocromil sodium produced a dose dependent inhibition of histamine secretion from human pulmonary mast cells obtained by bronchoalveolar lavage and by enzymatic dissociation of lung parenchyma. Both compounds were significantly more active against the lavage cells than against the dispersed lung cells, and nedocromil sodium was an order of magnitude more effective than sodium cromoglycate against both cell types. Tachyphylaxis was observed with the parenchymal cells but not with the lavage cells. Nedocromil sodium and sodium cromoglycate also inhibited histamine release from the lavage cells of patients with sarcoidosis and extrinsic asthma.
Introduction
Asthma is a complex, multifactorial disease characterised by non-specific bronchial hyperreactivity and inflammation of the airways. It Subsequently, lavage was carried out on subjects with extrinsic asthma and patients with biopsy proved sarcoidosis. The asthmatic subjects had one or more positive skin reactions to prick tests with 10 common inhalant antigens and medication was withdrawn before the lavage as previously described. 4 The diagnosis of sarcoidosis was based on previously defined criteria. 
Results
Both sodium cromoglycate and nedocromil sodium produced dose dependent inhibition of immunologically stimulated histamine secretion from dispersed human lung mast cells, though the effect was only seen clearly when the drugs were added simultaneously with the secretory stimulus. The activity of the compounds decreased sharply on preincubation with the cells and the maximum inhibition observed after 10 minutes' pretreatment did not generally exceed 15% for sodium cromoglycate or 20% for nedocromil sodium (fig 1) . A different pattern was observed with the lavage cells, where the activity of the drugs was unaffected by preincubation or if anything slightly increased (fig 2) . This effect was confirmed in six additional lavage samples with two selected, intermediate drug concentrations (table) . In each case the activity of the drugs was unaffected by preincubation with the lavage cells. The relative activities of sodium cromoglycate and nedocromil sodium were compared in parallel experiments in five studies using lavage cells and in eight using dispersed lung cells (fig 3) (fig 4) . Nedocromil sodium was again more active than sodium cromoglycate, though both drugs were apparently less potent than when they were used on cells from normal control subjects (fig 3) . This effect may reflect the hyperreactivity ofmast cells from patients with sarcoidosis and asthma and the corresponding increase in the concentrations of induced histamine secretion (see below).
Discussion
We have shown that sodium cromoglycate and nedocromil sodium both inhibited immunologically stimulated histamine release from lavage and isolated lung mast cells. The inhibition was dose dependent, nedocromil sodium being one order of magnitude more potent with both cell populations. Both drugs produced greater inhibition of histamine release from lavage mast cells than from lung parenchymal mast cells. A further difference was the clearcut tachyphylactic effect" 2 ofboth drugs on parenchymal mast cell histamine release and the absence of this effect on lavage cells. In fact, preincubation of lavage cells with the drug often led to increased inhibition of histamine release. Tachyphylaxis is not seen with these drugs in clinical practice, suggesting that the site of action in vivo is the lavage mast cell, which is presumably the first to encounter allergen, rather than the mast cell in the lung parenchyma. 
